Over 30 million people in Europe live with a rare disease. Most of them still lack access to accurate diagnosis or treatment ...

I-Mab (NASDAQ:IMAB) said on Thursday that it has signed an agreement to acquire Bridge Health Biotech. As part of the deal, I-Mab will provide an initial payment of $1.8M to Bridge Health shareholders ...

Brisbane-based biotech company Eclipse Ingredients has launched publicly with $7.2 million in funding after navigating a long ...

Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...

In a nation with ambitions as bold as Qatar’s, healthcare is more than a service — it is a cornerstone of progress, ...

Prof. Ganesan Karthikeyan, Executive Director of THSTI, opened the event by emphasizing the urgent need for multidisciplinary ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

The Health Ministry, Bandung Institute of Technology (ITB), and Del Technology Institute (IT Del) have inked a memorandum of understanding to bolster ...

The Philadelphia gene therapy company said the cuts were "part of a broader effort to right size the organization." ...